Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
This guide reviews which stablecoins are compliant and the standards they must meet. It helps you spot red flags and choose compliant options with confidence.
19,334 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Global worker engagement remains stuck near crisis levels, even as AI and remote work reshape the office. This story ...
Explore an investor-friendly view of Privia Health as it heads into 2025. This original analysis covers growth driver...
When a local emergency provider faces a court case over funds, it isn’t just a headline—it can affect budgets, bills,...
BITI posted a strong year-to-date gain as bitcoin declined, yet a wave of spot Bitcoin ETF inflows this week reversed...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Investors are watching Nomad Foods navigate a tough year. While the stock has fallen, there are hidden strengths and ...
The Trump administration presses more to accelerate domestic memory fabrication, aiming to reduce reliance on oversea...
ZKSync announced that ZKsync Lite will be deprecated on May 4 as the project consolidates around Era and the ZK Stack...
Karman Holdings stock zoomed more than 6% today as the company was added to a major index. Here’s what happened, why ...
Match Group's chief executive opened a direct message channel to employees, turning feedback into action and reshapin...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...